We are live on
!
Find out more
AP
AHL Partners Portfolio holdings
AUM
$6.41B
1-Year Est. Return
23.14%
This Fund
S&P 500
This Quarter
Est. Return
-5.7%
1 Year Est. Return
+23.14%
3 Year Est. Return
+67.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$630M
AUM Growth
-$1.88B
(-75%)
Cap. Flow
-$1.8B
Cap. Flow
% of AUM
-285.93%
Top 10 Holdings %
Top 10 Hldgs %
7.48%
Holding
900
New
79
Increased
66
Reduced
525
Closed
226
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$5.68M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$3.95M |
| 3 |
DF
Dean Foods Company
DF
|
+$3.77M |
| 4 |
Hershey
HSY
|
+$3.14M |
| 5 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$2.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
THOR
THORATEC CORPORATION
THOR
|
+$9.09M |
| 2 |
HNT
HEALTH NET INC
HNT
|
+$8.98M |
| 3 |
Cigna
CI
|
+$8.98M |
| 4 |
Edwards Lifesciences
EW
|
+$8.68M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$8.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 17.24% |
| 2 | Financials | 16.74% |
| 3 | Technology | 14.69% |
| 4 | Healthcare | 13.53% |
| 5 | Consumer Discretionary | 12.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INVX
501
Innovex International
INVX
$1.87B
| $359K | 0.06% |
6,169
+1,364
| +28% | +$86.9K |
|
502
Ligand Pharmaceuticals
LGND
$6.02B
| $358K | 0.06% |
6,691
-69,123
| -91% | -$4.19M |
|
503
PNC Financial Services
PNC
$100B
| $358K | 0.06% |
+4,009
| New | +$377K |
|
504
NVIDIA
NVDA
$5.01T
| $357K | 0.06% |
578,760
-672,840
| -54% | -$364K |
|
505
ExxonMobil
XOM
$651B
| $357K | 0.06% |
4,800
-1,179
| -20% | -$90.8K |
|
506
Citigroup
C
$222B
| $355K | 0.06% |
7,146
-74,612
| -91% | -$4.08M |
|
507
Mastercard
MA
$477B
| $355K | 0.06% |
3,939
+602
| +18% | +$56.6K |
|
508
Illumina
ILMN
$29.4B
| $354K | 0.06% |
2,071
-11,731
| -85% | -$2.37M |
|
|
PARA
509
DELISTED
Paramount Global Class B
PARA
| $354K | 0.06% |
8,866
-45,327
| -84% | -$2.2M |
|
510
IDEX
IEX
$16.5B
| $353K | 0.06% |
4,944
-7,648
| -61% | -$563K |
|
511
Nucor
NUE
$56.4B
| $351K | 0.06% |
9,355
-3,322
| -26% | -$142K |
|
|
SPR
512
DELISTED
Spirit AeroSystems
SPR
| $351K | 0.06% |
7,258
-11,818
| -62% | -$629K |
|
|
VR
513
DELISTED
Validus Hold Ltd
VR
| $350K | 0.06% |
7,773
+513
| +7% | +$23.2K |
|
514
Charles River Laboratories
CRL
$10.9B
| $349K | 0.06% |
5,488
-65,664
| -92% | -$4.72M |
|
515
Gentex
GNTX
$4.88B
| $348K | 0.06% |
22,472
-253,491
| -92% | -$4.03M |
|
516
International Paper
IP
$22.3B
| $348K | 0.06% |
9,716
-8,888
| -48% | -$377K |
|
517
Littelfuse
LFUS
$10.2B
| $346K | 0.05% |
3,797
-5,515
| -59% | -$502K |
|
518
Revvity
RVTY
$12.3B
| $345K | 0.05% |
7,510
-83,501
| -92% | -$4.15M |
|
|
VWR
519
DELISTED
VWR Corporation
VWR
| $344K | 0.05% |
13,391
-175,479
| -93% | -$4.6M |
|
520
Avnet
AVT
$7.33B
| $343K | 0.05% |
8,048
-7,194
| -47% | -$299K |
|
521
Boston Scientific
BSX
$65.8B
| $343K | 0.05% |
20,890
+3,074
| +17% | +$52.5K |
|
522
HEICO Corp
HEI
$48.9B
| $340K | 0.05% |
16,965
-31,370
| -65% | -$684K |
|
523
Teradyne
TER
$54.8B
| $338K | 0.05% |
18,744
-3,997
| -18% | -$73.7K |
|
524
Landstar System
LSTR
$6.8B
| $337K | 0.05% |
5,309
+2,308
| +77% | +$157K |
|
525
B&G Foods
BGS
$285M
| $336K | 0.05% |
+9,216
| New | +$290K |
|
Similar funds
RFS
CWAM
CCCA
HTG
GP
IH
GL
TAM
AHL Partners's Q3 2015 Portfolio in Review
As of Q3 2015, AHL Partners held 900 positions worth $630M, down 75% from $2.51B the previous quarter. Its ten largest holdings account for 7.5% of the portfolio.
AHL Partners withdrew a net $1.8B in Q3 2015, closing 226 positions and reducing 525 holdings. Its most notable exit was THORATEC CORPORATION, an estimated $9.09M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 17% of assets, up from 7.1% a quarter earlier, followed by Financials and Technology.
Against the trend, AHL Partners opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $5.71M.
- AHL Partners's largest Q3 2015 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 49,158 shares worth $5.71M.
- AHL Partners added most to Mead Johnson Nutrition Company in Q3 2015, an estimated $3.95M increase.
- AHL Partners's biggest Q3 2015 reduction was Edwards Lifesciences, cutting an estimated $8.68M.
- AHL Partners fully exited THORATEC CORPORATION in Q3 2015, selling an estimated $9.09M.
- AHL Partners's ten largest holdings make up 7.5% of its $630M portfolio in Q3 2015.
- AHL Partners opened 79 new positions and closed 226 in Q3 2015.
- AHL Partners's portfolio value fell 75% quarter-over-quarter to $630M.
Based on AHL Partners's 13F filing for Q3 2015, filed 16 Nov 2015.